These results provide evidence that low and high miR-148a expression may discriminate the survival rates of HCC patients, and MVI versus non-MVI, and that of the new targets up-regulated due to miR-148a dysregulation, a significant inverse correlation existed between miR-148a and USP4. This evidence concerns the gene USP4 and hepatocellular carcinoma.